These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33440998)

  • 1. Coxsackievirus B3 Infection Early in Pregnancy Induces Congenital Heart Defects Through Suppression of Fetal Cardiomyocyte Proliferation.
    Sharma V; Goessling LS; Brar AK; Joshi CS; Mysorekar IU; Eghtesady P
    J Am Heart Assoc; 2021 Jan; 10(2):e017995. PubMed ID: 33440998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple subtypes of coxsackievirus group B can cause congenital heart disease.
    Sharma V; Goessling LS; Brar AK; Eghtesady P
    Birth Defects Res; 2023 Jan; 115(2):171-178. PubMed ID: 36094067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
    Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
    Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
    Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.
    Althof N; Harkins S; Kemball CC; Flynn CT; Alirezaei M; Whitton JL
    J Virol; 2014 May; 88(9):5087-99. PubMed ID: 24574394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
    Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.
    Saraste A; Arola A; Vuorinen T; Kytö V; Kallajoki M; Pulkki K; Voipio-Pulkki LM; Hyypiä T
    Cardiovasc Pathol; 2003; 12(5):255-62. PubMed ID: 14507574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
    Wang Y; Gao B; Xiong S
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
    Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC
    Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
    Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
    PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
    Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
    Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper deficiency increases the virulence of amyocarditic and myocarditic strains of coxsackievirus B3 in mice.
    Smith AD; Botero S; Levander OA
    J Nutr; 2008 May; 138(5):849-55. PubMed ID: 18424590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.
    Kaese S; Larbig R; Rohrbeck M; Frommeyer G; Dechering D; Olligs J; Schönhofer-Merl S; Wessely R; Klingel K; Seebohm G; Eckardt L
    PLoS One; 2017; 12(6):e0180029. PubMed ID: 28644868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
    Pinkert S; Klingel K; Lindig V; Dörner A; Zeichhardt H; Spiller OB; Fechner H
    J Virol; 2011 Dec; 85(24):13409-19. PubMed ID: 21976640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy loss following coxsackievirus b3 infection in mice during early gestation due to high expression of coxsackievirus-adenovirus receptor (CAR) in uterus and embryo.
    Hwang JY; Lee KM; Kim YH; Shim HM; Bae YK; Hwang JH; Park H
    Exp Anim; 2014; 63(1):63-72. PubMed ID: 24521864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.